表紙
市場調査レポート

痙性両麻痺:世界の治験レビュー

Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014

発行 GlobalData 商品コード 309954
出版日 ページ情報 英文
即納可能
価格
本日の銀行送金レート: 1USD=101.75円で換算しております。
Back to Top
痙性両麻痺:世界の治験レビュー Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014
出版日: 2014年07月31日 ページ情報: 英文
概要

当レポートでは、痙性両麻痺に関する臨床研究の最新動向について分析し、疾患治療法の概要や、治験における主要国、G7諸国およびE7(新興7カ国)における治験数および被験者採用の状況、フェーズ(相)段階別の進行状況、有望なスポンサー、各企業研究機関での研究の進行状況、有望な薬剤の比較といった情報をまとめてお届けします。

目次

イントロダクション

  • 痙性両麻痺
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋の主要国における治験件数
    • 欧州の主要国における治験件数
    • 北米の主要国における治験件数
    • 中東およびアフリカの主要国における治験件数

G7諸国での治験件数:中枢神経系の治験件数に対する痙性両麻痺の治験件数比率

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国(新興7カ国)での治験件数:中枢神経系の治験件数に対する痙性両麻痺の治験件数比率

E7諸国(新興7カ国)での治験件数:フェーズ(相)別

フェーズ(相)別の治験件数

進捗状況別の治験件数

エンドポイント達成状況別の治験件数

一定期間に採用された被験者

  • 代表的な研究機関・病院の治験の概要
    • National Taiwan University Hospital
    • National Institute of Neurological Disorders and Stroke
    • Nanjing Hospital
    • Thammasat University
    • Ahvaz Jundishapur University of Medical Sciences
    • University of Heidelberg
    • Universita degli Studi di Modena e Reggio Emilia
    • Manipal University
    • Shriners Hospitals for Children

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GlobalData

GlobalData's clinical trial report, "Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Diplegia Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Diplegia Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Diplegia Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Spastic Diplegia Cerebral Palsy
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
    • Clinical Trial Overview of Top Institutes / Government
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Nanjing Hospital
      • Clinical Trial Overview of Nanjing Hospital
      • Thammasat University
      • Clinical Trial Overview of Thammasat University
      • Ahvaz Jundishapur University of Medical Sciences
      • Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
      • Universita degli Studi di Modena e Reggio Emilia
      • Clinical Trial Overview of Universita degli Studi di Modena e Reggio Emilia
      • Manipal University
      • Clinical Trial Overview of Manipal University
      • Shriners Hospitals for Children
      • Clinical Trial Overview of Shriners Hospitals for Children
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Hospital, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Thammasat University, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi di Modena e Reggio Emilia, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Manipal University, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014*

List of Figures

  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • GlobalData Methodology
Back to Top